Suraksha Diagnostic IPO
Suraksha Diagnostic IPO is listed on BSE and NSE, priced at ₹420–₹441 per share. The stock debuted at ₹438. The IPO had a lot size of ₹34 shares and a minimum investment of ₹14,994.
Suraksha Diagnostic Limited IPO
- IPO Dates
- Nov 29, 2024 – Dec 3, 2024
- Price band
- ₹420-441 per equity share
- Minimum Investment
- ₹14,994
- Issue size
- ₹846.25 Cr
- Lot size
- 34
- Allotment Date
- Dec 4, 2024
- Listing
- Dec 6, 2024
- Listing At
- BSE, NSE
IPO timeline
-
Nov 29, 2024
Open Date
Completed
-
Dec 3, 2024
Close Date
Completed
-
Dec 4, 2024
Allotment Date
Completed
-
Dec 6, 2024
Listing Date
Completed
Price Summary
- Last closing
- 302.15 (-31.49%)
- 52 week high
- 352.50
- 52 week low
- 224.10
- Last update
Suraksha Diagnostic IPO Essentials
Suraksha Diagnostic IPO Details
Suraksha Diagnostic IPO is priced at ₹420-441 per share with a total issue size of 846.25 crore. The IPO has a lot size of 34 shares and is listed on BSE and NSE.
- Issue price
- ₹420-441 per equity share
- Lot size
- 34 shares
- Face value
- ₹2 Per Equity Share
- Issue size
- OFS : 19,189,330 shares of ₹2(aggregating up to ₹846.2 Crores)
- Total issue size
- 1,91,89,330 shares
(aggregating up to ₹846.25 crore) - Offer for sale (OFS)
- 1,91,89,330 shares
(aggregating up to ₹846.25 crore) - Listing at
- BSE, NSE
- List price
- 438.0(NSE)
- Listing date
- Registrar
- Kfin Technologies Limited
- Lead manager
-
ICICI Securities Limited, Nuvama Wealth Management Limited, SBI Capital Markets Limited
Market Lot Size
Investors can bid for a minimum of 34 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 34 | ₹14,994 |
| Retail(max) | 13 | 442 | ₹1,94,922 |
Suraksha Diagnostic IPO Reservation
Suraksha Diagnostic IPO reservation details show category-wise allocation of shares. Out of the total 1,91,89,330 shares, approximately 20% are reserved for QIB, 15% for NII, 35% for retail investors, and 30% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 57,56,797 (30%) | |
| QIB Shares Offered | 38,37,867 (20%) | |
| NII (HNI) Shares Offered | 28,78,400 (15%) | |
| bHNI > ₹10L | 19,18,934 (10%) | 4,031 |
| sHNI < ₹10L | 9,59,466 (5%) | 2,015 |
| Retail Shares Offered | 67,16,266 (35%) | 1,97,537 |
| Total Shares Offered | 1,91,89,330 (100%) |
Suraksha Diagnostic IPO Analytics
Suraksha Diagnostic IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Suraksha Diagnostic IPO Subscription Status
Suraksha Diagnostic IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB |
NII
bHNI
sHNI
|
Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 3,837,867 |
2,878,400
1,918,934
959,466
|
6,716,266 | 13,432,533 |
|
Day 1
29-11-24 05:00 PM
|
0.00 x |
0.04x
0.02x
0.08x
|
0.20 x | 0.11 x |
|
Day 2
02-12-24 05:00 PM
|
0.00 x |
0.13x
0.08x
0.23x
|
0.45 x | 0.25 x |
|
Day 3
03-12-24 05:00 PM
|
1.74 x |
1.40x
1.53x
1.16x
|
0.94 x | 1.27 x |
|
Total No. of Applications
|
bHNI | sHNI | Retail |
|---|---|---|---|
| 1,47,938 (Approx) | —x | —x | 0.74x |
Suraksha Diagnostic Valuations
Earnings
- EPS Pre IPO
- ₹4.44/-
- EPS Post IPO
- ₹5.89/-
- P/E Pre IPO
- 99.31
- P/E Post IPO
- 74.89
Returns
- ROE
- 14.09%
- ROCE
- 21.46%
- RoNW
- 14.09%
- PAT Margin
- 10.57
Fundamentals
- Debt / Equity
- 0.20
- Price / Book
- 13.10
Suraksha Diagnostic Financials( In Crs.)
| 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|
| Assets | 300.21 | 281.20 | 275.96 |
| Revenue | 222.26 | 193.69 | 225.77 |
| Profit After Tax | 23.13 | 6.07 | 20.82 |
| Net Worth | 179.41 | 155.93 | 145.84 |
| Reserves & Surplus | 170.88 | 147.40 | 137.31 |
| Total Borrowing | 8.64 | 14.01 | 19.03 |
Suraksha Diagnostic Company & Offer Insights
About Suraksha Diagnostic
On March 15, 2005, Suraksha Diagnostic Limited began its operation as a leading technology-driven diagnostic chain in India. The company provides integrated pathology, radiology, and medical consultancy services under one umbrella with an excellent operational network. As of date, more than 2,300 specialized tests in various disciplines of medicine meet diverse health needs.
Comprehensive Diagnostic Network:Suraksha Diagnostic runs a state-of-the-art central reference laboratory supported by 8 satellite laboratories and 194 customer contact points, including 48 diagnostic centers and 146 sample collection centers. This extensive infrastructure thus provides seamless patient experience, convenient and accessible across eastern and northeastern India.
Besides offering diagnostic services, over 120 polyclinics function in 43 diagnostic centers with more than 750 doctors across the organization to offer in-house medical consultations for improving patient care.
Suraksha Diagnostic Promoter(s)
Dr. Somnath Chatterjee, Ritu Mittal, Satish Kumar Verma are the company's promoters of Suraksha Diagnostic.
Suraksha Diagnostic IPO Issue Objectives
- •
- The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.
Suraksha Diagnostic IPO - Anchor Investors
Suraksha Diagnostic raises Rs 254 cr via anchor subscribed ahead of Rs 846 Crore IPO.
Nippon Life India, Kotak Mutal Fund, Aditya Birla Sun Life Trustee, and Quant Mutual Fund are the biggest investors in the company through anchor book, acquiring 7.93 lakh equity shares worth Rs 35 crore each, while Carnelian Bharat Amritkaal Fund picked 6.8 lakh shares worth Rs 30 crore.
Mirae Asset, JM Financial, Bandhan Mutual Fund, Troo Capital, Intergrated Core Strategies, Tusk Investments Equity Fund, and Societe Generale are other investors participated in the anchor book.
Suraksha Diagnostic IPO - Peers Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Suraksha Diagnostic Limited | 4.43 | 4.43 | 33.66 | N/A | 14.09 | N/A | Consolidated |
| Dr Lalchandani Labs Ltd | 43.05 | 42.98 | 221.47 | 77.08 | 20.35 | 0.07 | Consolidated |
| Metropolis Healthcare Ltd | 24.95 | 24.87 | 213.98 | 89.61 | 12.26 | 8.05 | Consolidated |
| Thyrocare Technologies Ltd | 13.42 | 13.4 | 99.48 | 65.52 | 13.34 | 5.93 | Consolidated |
| Vijaya Diagnostic Centre Limited | 11.62 | 11.59 | 64.21 | 86.4 | 19.77 | 9.91 | Consolidated |
Notes:
- The P/E Ratio has been computed based on the closing market price of equity shares on July 12, 2024, divided by the Diluted EPS.
- Return on Net Worth (%) = Net profit after tax, as restated / Average shareholders' equity (including minority interest) as restated at year/period end.
- NAV is computed as the closing net worth (excluding minority interest) divided by the closing outstanding number of equity shares.
- Net worth means the aggregate value of the paid-up share capital of the Company and all reserves created out of profits and securities premium account and debit or credit balance of profit and loss account, after deducting the aggregate value of the accumulated losses, miscellaneous expenditure not written off, as per the restated balance sheet, but does not include reserves created out of revaluation of assets, write-back of depreciation as at year/period end, as per Restated Financial Statement of Assets and Liabilities of the Company.
Suraksha Diagnostic IPO - Strengths and Risks
Suraksha Diagnostic IPO strengths and risks highlight key business factors, financial position, and market sentiment that may impact investor interest.
Strengths
Risks
Contact Information
Contact Details
Suraksha Diagnostic
+91 33 66059750
Plot No. DG-12/1, Action Area 1D, Premises No. 02-0327, New Town, Rajarhat Kolkata 700 156
Registrar Contact Details
Kfin Technologies Limited
04067162222, 04079611000
Frequently Asked Questions
Click any question to reveal the answer
Suraksha Diagnostic IPO is a book-built IPO worth ₹846.25 crore. The price band is ₹420–₹441 per share. The IPO opens on Nov 29, 2024 and closes on Dec 3, 2024. It will be listed on BSE and NSE. Kfin Technologies Limited is the registrar.
The price band of Suraksha Diagnostic IPO is ₹420 to ₹441 per share.
The lot size of Suraksha Diagnostic IPO is 34 shares.
The minimum investment for Suraksha Diagnostic IPO is approximately ₹14,994 based on the upper price band .
Suraksha Diagnostic IPO opens on Nov 29, 2024 and closes on Dec 3, 2024.
The allotment date of Suraksha Diagnostic IPO is Dec 4, 2024.
Suraksha Diagnostic IPO is expected to be listed on Dec 6, 2024, on BSE and NSE .
Suraksha Diagnostic IPO listed on Dec 6, 2024. It was issued at ₹438.0(NSE) and is currently around ₹302.15 as on 14-May-2026 3:30 PM, which is approximately -31.5% versus issue price. The 52-week high is ₹352.50.
Based on listing and post-listing performance, Suraksha Diagnostic IPO delivered around -31.5% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.
To buy Suraksha Diagnostic IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.
Suraksha Diagnostic IPO valuation snapshot: P/E 74.89, EPS ₹5.89/-, P/B 13.10, RoNW 14.09%, and market cap N/A.
To apply for Suraksha Diagnostic IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Suraksha Diagnostic IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Suraksha Diagnostic IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Suraksha Diagnostic IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Suraksha Diagnostic IPO allotment status on IPO Ji for quick and easy access.